Eton Pharmaceuticals Inc (ETON)
3.71
-0.04
(-1.07%)
USD |
NASDAQ |
May 03, 16:00
3.74
+0.03
(+0.81%)
After-Hours: 20:00
Eton Pharmaceuticals Revenue (TTM): 31.64M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.64M |
| September 30, 2023 | 32.83M |
| June 30, 2023 | 29.02M |
| March 31, 2023 | 24.38M |
| December 31, 2022 | 21.25M |
| September 30, 2022 | 18.85M |
| June 30, 2022 | 16.40M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.11M |
| December 31, 2021 | 21.83M |
| September 30, 2021 | 15.82M |
| June 30, 2021 | 14.88M |
| March 31, 2021 | 11.84M |
| December 31, 2020 | 0.039M |
| September 30, 2020 | 0.417M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.039M
Minimum
Dec 2020
32.83M
Maximum
Sep 2023
17.95M
Average
17.62M
Median
Revenue (TTM) Benchmarks
| Eli Lilly and Co | 35.93B |
| Evoke Pharma Inc | 5.181M |
| Outlook Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |